Dengue Fever Cure Claim False

Dengue Fever Cure Claim False

Queensland Health is warning that claims a cure for dengue fever has been developed are false.

A team of Queensland scientists claim to have found a cure for dengue fever, using the Melaleuca tree. Dr Max Reynolds former professor at Griffith University told ABC Local Radio, that his team has created a drug using a Melaleuca leaf concentrate that has been scientifically proven to cure all four strains of dengue fever. “We have actually finished up to phase three trials now in Indonesia on 504 patients,” he said. “In the case of the treated, because this was a double blind, which means fifty per cent received the treatment and 50 per cent did not, it was one hundred per cent successful.” Professor Reynolds says they plan to have it on the market by next year. “The goal is to have people take the drug when the dengue season commences so that if they do get bitten and contract the virus, the virus is killed instantly within the blood stream,” he said.

However, Queensland Health’s Public Health Physician for North Queensland, Dr Steven Donohue says it is a wild and unsubstantiated claim and he would not recommend anyone use the drug. “Dengue affects about one hundred million people all over the world every year, causing thousands of deaths,” he said. “If they really had made such a momentous discovery … there would have been a Nobel prize in the offering, not a little media release in Queensland. “All they have done is show that the well-known antiseptic properties of tea tree are able to kill dengue and other viruses in the test tube, which we already knew. “They do not have randomised control trial evidence … therefore it is not published and it is not in any peer review journal.”

In a statement to the ABC, a Griffith University spokesperson said Dr Reynolds ceased working for the University in June 2012 and they could not support his dengue research. “The University has previously assessed research data by Dr Reynolds in relation to his dengue fever project and informed him it could not support his research.” The drug has been approved for consumer use, by the Therapeutic Goods Administration.

Comments are closed